Neovascular (wet) age-related macular degeneration (AMD)

Neovascular (wet) age-related macular degeneration (AMD) affects 90% 90% of cases of severe vision loss due to AMD. AMD is the leading cause of severe, irreversible vision loss in individuals over the age of 50. It causes blurred vision or a blind spot in the visual field. It’s generally caused by abnormal blood vessels that leak fluid or blood into the macula.

Showing all 6 results

Filter our product list:

Product Batch	Antigen	Molecular Class	Drug Brand	Product Concentration	CoA	Quantity per vial	Storage Temperature	Expiry Date	Price from
Brolucizumab	VEGF-A	Monoclonal Antibody	Beovu®	120 mg/mL	–	3 mg	tba	tba	883,00 €	view product Max: Min: 3 Step: 1
Faricimab	VEGF-A	Monoclonal Antibody	Vabysmo®	120 mg/mL	–	2.4 mg	tba	tba	618,00 €	view product Max: 50 Min: 5 Step: 1
Ranibizumab	VEGF-A	Monoclonal Antibody	Lucentis®	10 mg/mL	–	0.2 mg	tba	tba	680,00 €	view product Max: Min: 4 Step: 1
Ranibizumab	VEGF-A	Biosimilar , Monoclonal Antibody	Ranivisio®	10 mg/mL	–	0.2 mg	tba	tba	680,00 €	view product Max: Min: 5 Step: 1
Ranibizumab	VEGF	Biosimilar , Monoclonal Antibody	Ximluci®	10 mg/mL	–	0,21 mg	tba	tba	680,00 €	view product Max: 10 Min: 5 Step: 1
Ranibizumab	VEGF	Monoclonal Antibody	Byooviz®	10 mg/mL	–	0,21 mg	tba	tba	621,00 €	view product Max: 10 Min: 5 Step: 1